Most recently, the foundation, which is more than twice the size of the Gates Foundation, allocated $1.3 billion of its $167 billion endowment to research and humanitarian grants
Patients are generally recommended 4 treatments spread over 2 weeks, but sometimes this can vary, based on the individuals needs
Comparison to regular IGF-1 Mechanism of action IGF-1 LR3's effectiveness stems from its sophisticated mechanism of action within the body
FDA approval in the US is expected in 2026 to 2027, with Health Canada approval likely following
Major health insurance providers tend to offer several different types of plans, whether employer-sponsored or individually obtained
More importantly, patients with gastroparesis or severe gastrointestinal symptoms may not tolerate dose escalation, leaving them at subtherapeutic doses